Nasdaq Delisting: LakeShore Biopharma Shifts to OTC Market Due to Minimum Price Requirements Chinese biotech LakeShore Biopharma transitions from Nasdaq to OTC Pink Market trading under LSBCF following minimum bid price non-compliance. SEC reporting status maintained.

#LSB #LSBCF #LSBWF LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting

www.stocktitan.net/news/LSB/lake-shore-biop...